Antibiotic resistance pattern and clinical outcomes in acute cholecystitis: 567 consecutive worldwide patients in a prospective cohort study

International Journal of Surgery

Volumn 21, Issue , 2015, Pages 32-37

  Coccolini, Federico ^a   Sartelli, Massimo ^b   Catena, Fausto ^c   Montori, Giulia ^a   Di Saverio, Salomone ^d   Sugrue, Michael ^e,f   Ceresoli, Marco ^a   Manfredi, Roberto ^a   Ansaloni, Luca ^a  

^a PAPA GIOVANNI XXIII HOSPITAL   (Italy)

^b Macerata Hospital   (Italy)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

^d MAGGIORE HOSPITAL   (Italy)

^e LETTERKENNY GENERAL HOSPITAL   (Ireland)

^f UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Acute cholecystitis; Antibiotic; Antimicrobial; Bacteriology; Infection; Peritonitis; Spectrum; Therapy

Indexed keywords

CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE; POLYPEPTIDE ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ACUTE CHOLECYSTITIS; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM ISOLATION; BACTEROIDES; CANDIDA ALBICANS; CHOLECYSTECTOMY; CLOSTRIDIUM; COHORT ANALYSIS; COMMUNITY ACQUIRED INFECTION; CONSERVATIVE TREATMENT; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PERITONITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEUS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; SURGICAL DRAINAGE; VANCOMYCIN RESISTANT ENTEROCOCCUS; BACTERIUM; CHOLECYSTITIS, ACUTE; CLINICAL TRIAL; DRUG EFFECTS; FOLLOW UP; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTICENTER STUDY;

AGED; ANTI-BACTERIAL AGENTS; BACTERIA; CHOLECYSTITIS, ACUTE; DRUG RESISTANCE, MICROBIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84941212460     PISSN: 17439191     EISSN: 17439159     Source Type: Journal    
DOI: 10.1016/j.ijsu.2015.07.013     Document Type: Article

References (30)

1. Menichetti F., Sganga G. Definition and classification of intra-abdominal infections. J. Chemother. 2009, 1)(21Suppl. l):3-4.
2. Marshall J.C., Maier R.V., Jimenez M., Dellinger E.P. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit. Care Med. 2004, 32(11 Suppl. l):S513-S526.
3. Pieracci F.M., Barie P.S. Management of severe sepsis of abdominal origin. Scand. J. Surg. 2007, 96(3):184-196.
4. Sartelli M., Catena F., Ansaloni L., Coccolini F., Corbella D., Moore E.E., et al. Complicated intra-abdominal infections worldwide: the definitive data of the CIAOW Study. World J. Emerg. Surg. 2014 May 14, 9:37.
5. Claesson B., Holmlund D., Matzsch T. Biliary microflora in acute cholecystitis and the clinical implications. Acta Chir. Scand. 1984, 150:229-237.
6. Thompson J.E., Bennion R.S., Doty J.E., Muller E.L., Pitt H.A. Predictive factors for bactibilia in acute cholecystitis. Arch. Surg. 1990, 125:261-264.
7. Csendes A., Becerra M., Burdiles P., Demian I., Bancalari K., Csendes P. Bacteriological studies of bile from the gallbladder in patients with carcinoma of the gallbladder, cholelithiasis, common bile duct stones and no gallstones disease. Eur. J. Surg. 1994, 160:363-367.
8. Morris-Stiff G.J., O'Donohue P., Ogunbiyi S., Sheridan W.G. Microbiological assessment of bile during cholecystectomy: is all bile infected?. HPB Oxf. 2007, 9:225-228.
9. Truedson H., Elmros T., Holm S. The incidence of bacteria in gallbladder bile at acute and elective cholecystectomy. Acta Chir. Scand. 1983, 149:307-313.
10. Claesson B.E., Holmlund D.E., Matzsch T.W. Microflora of the gallbladder related to duration of acute cholecystitis. Surg. Gynecol. Obstet. 1986, 162:531-535.
11. Galili O., Eldar S., Matter I., Madi H., Brodsky A., Galis I., et al. The effect of bactibilia on the course and outcome of laparoscopic cholecystectomy. Eur. J. Clin. Microbiol. Infect. Dis. 2008, 27:797-803.
12. Csendes A., Burdiles P., Maluenda F., Diaz J.C., Csendes P., Mitru N. Simultaneous bacteriologic assessment of bile from gallbladder and common bile duct in control subjects and patients with gallstones and common duct stones. Arch. Surg. 1996, 131:389-394.
13. Fuks D., Cossé C., Régimbeau J.M. Antibiotic therapy in acute calculous cholecystitis. J. Visc. Surg. 2013, 150:3-8.
14. Sartelli M., Viale P., Catena F., Ansaloni L., Moore E., Malangoni M., et al. 2013 WSES guidelines for management of intra-abdominal infections. World J. Emerg. Surg. 2013, 8:3.
15. Shani V., Muchtar E., Kariv G., Robenshtok E., Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob. Agents Chemother. 2010, 54(11):4851-4863.
16. Ferrer R., Artigas A., Suarez D., Palencia E., Levy M.M., Arenzana A., et al. Edusepsis study group: effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am. J. Respir. Crit. Care Med. 2009, 180:861-866.
17. Castellanos-Ortega A., Suberviola B., García-Astudillo L.A., Holanda M.S., Ortiz F., Llorca J., et al. Impact of the surviving sepsis campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study. Crit. Care Med. 2010, 38:1036-1043.
18. Puskarich M.A., Trzeciak S., Shapiro N.I., Arnold R.C., Horton J.M., Studnek J.R., et al. Emergency medicine shock research network (EMSHOCKNET): emergency medicine shock research network (EMSHOCKNET): association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit. Care Med. 2011, 39:2066-2071.
19. Sartelli M., Catena F., Di Saverio S., Ansaloni L., Malangoni M., Moore E.E., et al. Current concept of abdominal sepsis: WSES position paper. World J. Emerg. Surg. 2014 Mar 27, 9(1):22.
20. Marshall J.C. Principles of source control in the early management of sepsis. Curr. Infect. Dis. Rep. 2010, 12(5):345-353.
21. Marshall J.C., al Naqbi A. Principles of source control in the management of sepsis. Crit. Care Clin. 2009, 25(4):753-768.
22. Sartelli M., Catena F., Coccolini F., Pinna A.D. Antimicrobial management of intra-abdominal infections: literature's guidelines. World J. Gastroenterol. 2012, 18(9):865-871.
23. Sartelli M., Catena F., Ansaloni L., Leppaniemi A., Taviloglu K., van Goor H., et al. Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study. World J. Emerg. Surg. 2012 Nov 29, 7(1):36.
24. Asai K., Watanabe M., Kusachi S., Tanaka H., Matsukiyo H., Osawa A., et al. Bacteriological analysis of bile in acute cholecystitis according to the Tokyo guidelines. J. Hepatobiliary Pancreat. Sci. 2012, 19:476-486.
25. Wacha H., Hau T., Dittmer R., Ohmann C. Risk factors associated with intraabdominal infections: a prospective multicenter study. Peritonitis study group. Langenbecks Arch. Surg. 1999, 384:24-32.
26. Fry D. The generic response. Crit. Care Med. 2008, 36:1369-1370.
27. Tumbarello M., Trecarichi E.M., Bassetti M., De Rosa F.G., Spanu T., Di Meco E., et al. Identifying patients harboring extended-spectrum-beta-lactamase-producing enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob. agents Chemother. 2011, 3485-3490.
28. Johnson S.W., Anderson D.J., May D.B., Drew R.H. Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admission. Infect. Control Hosp. Epidemiol. 2013, 34(4):385-392.
29. Shitrit P., Reisfeld S., Paitan Y., Gottesman B.S., Katzir M., Paul M., et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae carriage upon hospital admission: prevalence and risk factors. J. Hosp. Infect. 2013, 85:230e232.
30. SW1 Lee, Yang S.S., Chang C.S., Yeh H.J. Impact of the Tokyo guidelines on the management of patients with acute calculous cholecystitis. J. Gastroenterol. Hepatol. 2009 Dec, 24(12):1857-1861. 10.1111/j.1440-1746.2009.05923.x.